about
ATP bindingoxygen bindingcobalamin bindingcocaine bindingdopamine bindingfolic acid bindingAMP bindingdiazepam binding1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine bindingcalcitriol bindingcalcitonin bindingmuramyl dipeptide bindingglycine bindingtetrahydrobiopterin bindingacetylcholine bindingethanol bindingcyclosporin A bindingchitin bindingmethotrexate bindinginositol hexakisphosphate bindingmacrolide bindingpolychlorinated biphenyl bindingcyclic-di-GMP bindingbiotin bindingL-DOPA binding5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid bindingcalcidiol bindingsuramin bindinguracil bindingcarbon monoxide bindingS-adenosyl-L-methionine bindingthiamine bindingpenicillin bindingpectin bindingglucomannan bindingquercitrin bindingepigallocatechin 3-gallate bindingcortisol bindingmelatonin bindingN-1-naphthylphthalamic acid binding
P279
Peroxisome proliferator activated receptor gammaCubilinAlbuminAngiotensin I converting enzymeDihydrofolate reductaseAngiotensin I converting enzyme (peptidyl-dipeptidase A) 1Acrosin prepropeptideAlbuminSolute carrier family 6 (neurotransmitter transporter, dopamine), member 3Dopamine receptor D4Chemokine (C-X-C motif) receptor 45-hydroxytryptamine (serotonin) receptor 2ANuclear receptor subfamily 1, group I, member 2Thymidylate synthaseToll-like receptor 7Deoxycytidine kinaseSolute carrier family 18 (vesicular monoamine), member 2Adrenergic receptor, beta 1Purine-nucleoside phosphorylaseCalcium-sensing receptorEstrogen receptor 2 (beta)Dopamine receptor D25-hydroxytryptamine receptor 2ADopamine receptor D2ATPase Na+/K+ transporting subunit beta 1ATPase Na+/K+ transporting subunit alpha 2Glycine receptor betaPhosphodiesterase 2AFatty acid binding protein 1Phosphodiesterase 4DFolate receptor betaFolate receptor alpha5-hydroxytryptamine receptor 2CDNA topoisomerase II alphaPurinergic receptor P2X 4ATP synthase peripheral stalk subunit OSCPCytochrome P450 family 4 subfamily B member 1FKBP prolyl isomerase 1ADopamine receptor D3Cholinergic receptor nicotinic beta 2 subunit
P680
Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structuresKinetics of interaction of local anesthetics with human serum albuminHuman kidney amiloride-binding protein: cDNA structure and functional expressionSalvicine functions as novel topoisomerase II poison by binding to ATP pocketBinding studies of taxanes to human serum albumin by bioaffinity chromatography and circular dichroismStudy of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approachA new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic propertiesFatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gammaDopamine D4 receptors elevated in schizophreniaIdentification and mechanism of action of the acylguanidine MRT-83, a novel potent Smoothened antagonistStructure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistryCloning and functional expression of the human type 1 sigma receptor (hSigmaR1)
P921
Q14817981-584E6390-EB3F-4ADE-95D3-90938A014BC6Q14819285-FDE54CD1-BC8A-4EBF-8206-F37F21549381Q14859650-B00A5606-5A10-44DA-9F0C-5D89FDEF401CQ14860804-C6648EA9-7333-4AD2-B1EB-81CA7A44FB88Q14865365-F5CC529C-DDC7-4B90-BA92-4A126AD5EA21Q14876919-7149613A-1A4E-4176-A0DA-2F5C9A37CD9EQ14878323-93B9313A-EE0D-4A15-8381-C847806C03CAQ14882461-2B3801D4-2BDD-4E2C-93F9-001FE097BDBEQ14891385-1A446734-1310-4476-A854-B123D27C59E9Q14904921-823BC750-355D-4F7D-9FE8-A196659EBC56Q14905624-C7A43AB9-0E48-49F3-811A-E89F1EF3AB20Q14912558-1E7D54ED-91CA-4C37-A7E8-3CC6FF66C6E9Q14914210-30F007E4-6440-4060-A857-DD42A4870A84Q14916294-93F83DAB-F521-44E3-B5D1-313252D98AD3Q21096320-D115813F-3DAE-4390-9B6C-C65A05844E83Q21096465-9C30A327-7BAD-416E-836E-A65060997CB4Q21100341-5A9DB897-2B9E-4969-806F-24C4625A9A5DQ21100750-B6835F86-AA4A-4090-AAA4-2942E85C94B2Q21107375-F12E0842-AB8B-4E47-B5E4-E5FF5A4204FCQ21107803-AFB1014D-DEC7-4977-BCFF-584A1C568AD1Q21110394-91429F45-EA50-4F33-8974-6FF61A3360EBQ21110888-453D2314-04ED-4690-B1B6-38EE4C40F6B7Q21112987-1562B892-293D-406B-8A86-187DA39E477AQ21113700-9043C8FD-DC4D-4EBC-8276-2F11F3B4932EQ21118969-60A40E2A-6DD3-4B27-A767-438C259DEE7AQ21122458-A813BDA2-569A-402B-A0AB-91CC78B859A4Q21125699-A15DC9E7-C40E-436D-AD9E-B357AF92A84AQ21155019-E5A535CB-4D6D-47E4-A61A-65433A1FE09FQ21173257-6164B642-5345-432C-A5B7-DD788ED03478Q21173638-3F94093B-5F97-4993-AFB6-FCF05294C7CEQ21173639-99FF7524-968C-45BE-8471-499922982AB8Q21174212-C95A2CDE-BC65-4EAC-847C-FD923D8D66CCQ21199060-11E401CE-69DE-4A0C-A93B-B979D86DF9E6Q22313177-F9DC249B-5E48-46DE-8DF9-20C2D4BA8080Q22313182-ED2B691B-2DFF-4A52-919F-559E2D7FD43EQ22313264-1ECD361D-9616-40BF-BEB4-68BE8B89D968Q22313478-2C6A6BE8-20CE-4909-810E-A53194C30AEEQ22313541-E4AE362F-7437-4A74-AAD3-9235676BB33CQ22313595-A6D0003D-B739-4F71-97BF-14B76AB21F55Q22313606-FBF4C21F-EB9D-412A-B2F7-C52B873D5318
P279
Q1084878-34483734-181B-4A64-9A46-8216981285B0Q1084878-7EF107C6-2D43-4794-B8EE-B3BF5AD128E8Q1142947-1EAA4370-9FA7-4EE0-BF24-D6EED0E6DE5BQ1142947-56E36FCB-CD96-4D79-8AD0-BBEA045D1124Q11721976-272DF42E-495E-4208-B20B-821392C5556FQ128861-D2534B1F-A0E0-4618-B65F-EB579545F314Q14819390-E3CC7A6E-4233-4CDB-B2BC-3179311BA089Q14864000-0203D715-DB63-4B54-98AE-0DB0009521DDQ14864000-F0524ABC-3F33-42D9-B4EA-F6E6A4C8B0A8Q14864907-44E29C96-8199-4E19-93EB-4FA2A8C4E57AQ14865034-15CA58AA-91D0-49D3-B2C5-E20FD56901F5Q14865375-A9A00468-38CA-4114-9F2B-CC48E275228BQ14866083-D9763F0A-4163-40E8-B009-960E5BAEA456Q14874287-3E0D8D86-598F-4C1D-9090-F17BADD4D119Q14891461-DC59E0CC-3831-4074-B81D-0A7738F513D6Q14905076-81274B74-9648-4AED-83BD-54F68CA8B582Q14911895-9EB58644-DF58-4FE0-8FB3-DD103AC79A28Q14914083-1F8D399E-7F73-49DA-8BAB-086AA9915800Q14914179-4DDBFB48-6806-4BB2-8CD9-1DCC77FF2C07Q14916237-B62528F8-D5E0-4925-B492-E8C20CEAA59EQ14916366-FA4DB422-5F74-4634-93BA-1CE56AC7CC10Q14916514-1C95C714-CFB1-4775-9F72-DFED7D1BE165Q15321300-4E79C757-C7D5-4F5F-B24A-A5E7694D0034Q15329166-8A5AB412-A629-4854-AB00-DC033837DF89Q15335226-C7297CAD-4728-4389-9E24-C8A66C4FC2A0Q1949517-BFF04585-6F4A-47CB-BBF0-E51C1B8EE266Q2034004-3FB6EEA0-32DE-4691-8BCB-3B1E1146419EQ21097497-39E6F74E-BCC1-4034-9670-973153F71123Q21097513-53CA495B-D890-4CBA-A7B1-F69373832AF6Q21103162-133EA194-B7A5-4526-9427-3FC928CD2B2DQ21105011-15D1CB0B-764A-4E83-8109-42D41B6DBFBFQ21106023-80230A4C-B962-4FCA-BF85-98EE69FEC515Q21106795-7F9F4521-B76C-408A-8A6A-7A9132653384Q21107380-F33C5835-9A4D-4D7B-80E3-2ACEC805DECFQ21107386-520CEBCF-2EBF-454A-8047-F1A10198E393Q21108118-30C919AD-557B-4837-8D99-F5CFFA77A2B0Q21108482-0A11B2DB-FE73-4E6C-8B34-1A264A4EDBADQ21108844-67569090-A85A-4C8D-872A-2B98C9E8EC4CQ21109360-9CC14347-20CC-40CD-8D7E-0645A767286DQ21109897-668D557E-68B1-4571-A36C-19117B32DBFA
P680
Q24273429-42C43048-50B6-427E-8ACC-F309F5B5C143Q24296946-0CE10EAC-BC46-4C32-8A89-E7944A4F345EQ24299930-BDEE3D6E-CADF-4663-941D-7A189980EF4EQ24299990-A7B56410-A874-4C1E-9868-79EBC5151910Q24301134-5183108D-9CAA-42C3-9702-9E011081249CQ24301151-669FAEC4-2DC9-423C-A784-5484F15450EAQ24309030-333E81F7-AAD2-4105-8F19-4B0808D09F82Q24314755-1E940CA9-76B3-4830-947C-57B155073D4FQ24318936-9000F1CE-2F9E-4F7C-8E84-CD1BD435322AQ24319081-AF209159-C28B-4ED9-B8D8-784B19B9698BQ24319682-2C4E1B22-D805-475F-BB9F-31FE29CFF717Q24336165-FE64D305-A6E8-4240-870E-E0244C4A445E
P921
description
Interacting selectively and no ...... e organism; in particular, any
@en
moleculaire functie
@nl
name
drug binding
@en
liaison de médicament
@fr
vezivanje leka
@sr-el
везивање лека
@sr
везивање лека
@sr-ec
зьвязваньне лекаў
@be-tarask
type
label
drug binding
@en
liaison de médicament
@fr
vezivanje leka
@sr-el
везивање лека
@sr
везивање лека
@sr-ec
зьвязваньне лекаў
@be-tarask
altLabel
GO:0008144
@en
prefLabel
drug binding
@en
liaison de médicament
@fr
vezivanje leka
@sr-el
везивање лека
@sr
везивање лека
@sr-ec
зьвязваньне лекаў
@be-tarask
P279
P2888
P686
GO:0008144